Clicky

Nuvalent, Inc.(NUVL) News

Date Title
Dec 19 Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 9 Nuvalent Appoints Grant Bogle to Board of Directors
Sep 19 Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates
Sep 18 Nuvalent Announces Closing of Upsized Public Offering of Common Stock
Sep 18 Nuvalent Stock Moves Up 20% in a Week: What's Driving the Rally?
Sep 17 Company News for Sep 17, 2024
Sep 17 Nuvalent Announces Pricing of Upsized Public Offering of Common Stock
Sep 16 Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths
Sep 16 Cancer Biotech Nuvalent’s Stock Jumps on Positive Data
Sep 16 Nuvalent Announces Public Offering of Common Stock
Sep 14 Nuvalent, Inc. (NUVL): Among Hedge Funds’ Top Biotech Stock Picks
Sep 14 Nuvalent, Inc. (NUVL): Short Seller Sentiment is Bearish on This Cancer Stock
Sep 14 Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines
Sep 13 Nuvalent Announces Publication in Cancer Discovery Detailing Design and Characterization of ALK-selective inhibitor NVL-655
May 9 Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results
May 8 Why Earnings Season Could Be Great for Nuvalent (NUVL)
Apr 8 Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024
Apr 5 Chief Legal Officer Deborah Miller Sells 3,000 Shares of Nuvalent Inc (NUVL)
Apr 5 ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
Mar 29 Chief Legal Officer Deborah Miller Sells 22,000 Shares of Nuvalent Inc (NUVL)